CoChat

OX 40L blockade and allergen‐induced airway responses in subjects with mild asthma

Open access
Gauvreau, G. M., Boulet, L.‐P., Cockcroft, D. W., FitzGerald, J. M., Mayers, I., Carlsten, C., Laviolette, M., Killian, K. J., Davis, B. E., Larché, M., Kipling, C., Dua, B., Mosesova, S., Putnam, W., Zheng, Y., Scheerens, H., McClintock, D., Matthews, J. G., O'Byrne, P. M. · 2014 · Clinical & Experimental Allergy
Cited by 104

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Summary: Background: The OX 40/OX 40L interaction contributes to an optimal T cell response following allergic stimuli and plays an important role in the maintenance and reactivation of memory T effector cells. Objective: We tested whether treatment with an anti‐OX 40L monoclonal antibody (MA b) would inhibit allergen‐induced responses in subjects with asthma. Methods: Twenty‐eight mild, atopic asthmatic subjects were recruited for a double‐blind, randomized, placebo‐controlled, parallel‐group trial (ClinicalTrials.gov identifier NCT 00983658) to compare blockade of OX 40L using a humanized anti‐OX 40L MA b to placebo‐administered intravenously in 4 doses over 3 months. Allergen inhalation challenges were carried out 56 and 113 days after the first dose of study drug. The primary outcome variable was the late‐phase asthmatic response. Other outcomes included the early‐phase asthmatic response, airway hyperresponsiveness, serum IgE levels, blood and sputum eosinophils, safety and tolerability. Results: Treatment with anti‐OX 40L MA b did not attenuate the early‐ or late‐phase asthmatic responses at days 56 or 113 compared with placebo. In the anti‐OX 40L MA b treatment group, total IgE was reduced 17% from pre‐dosing levels, and sputum eosinophils decreased 75% by day 113 (both P = 0.04). There was no effect of anti‐OX 40L MA b on airway hyperresponsiveness or blood eosinophils. The frequency of AE s was similar in both groups. Conclusion and Clinical Relevance: Pharmacological activity of anti‐OX 40L MA b was observed by decreases in serum total IgE and airway eosinophils at 16 weeks post‐dosing, but there was no effect on allergen‐induced airway responses. It is possible that the treatment duration or dose of antibody was insufficient to impact the airway responses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cea.12235

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 104

Metadata

Authors
Gauvreau, G. M., Boulet, L. ‐., Cockcroft, D. W., FitzGerald, J. M., Mayers, I., Carlsten, C., Laviolette, M., Killian, K. J., Davis, B. E., Larché, M., Kipling, C., Dua, B., Mosesova, S., Putnam, W., Zheng, Y., Scheerens, H., McClintock, D., Matthews, J. G., & O'Byrne, P. M.
Venue
Clinical & Experimental Allergy
Publisher
Wiley
Published
2013-12-20
Volume
44
Issue
1
Pages
29-37
ISSN
  • 0954-7894 (ISSN-L)
  • 1365-2222
OpenAlex
W2111974349
Cited by
104
References
3
FWCI
7.75
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.